Evidence map›Paper›PMID 33531296›Full record

ArticleIEEE transactions on bio-medical engineering2021

Mapping Cell Viability Quantitatively and Independently From Cell Density in 3D Gels Noninvasively.

Brian J Archer, Julia J Mack, Sara Acosta, Russell Nakasone, Fadi Dahoud, Khalid Youssef, Abraham Goldstein, Amichai Goldsman, Mathias C Held, Martin Wiese and 6 more

Abstract read
In one paragraph

Article in IEEE transactions on bio-medical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Brian J Archer
Julia J Mack
Sara Acosta
Russell Nakasone
Fadi Dahoud
Khalid Youssef
Abraham Goldstein
Amichai Goldsman
Mathias C Held
Martin Wiese
Bernhard Blumich
Matthias Wessling
Meike Emondts
Jurgen Klankermayer
M Luisa Iruela-Arispe
Louis-S Bouchard

Funding

Vascular Biology Training GrantT32HL069766 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2002 to 2022
$7.4M
Systems Genetics Dissection of Non-alcoholic SteatohepatitisR01DK117850 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Aldons Jake Lusis · 2019 to 2026
$4.6M
Induction of Vascular MorphogenesisR01HL114086 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOUCHARD, LOUIS, IRUELA-ARISPE, M. LUISA · 2013 to 2016
$2.1M
NHLBI NIH HHS R01 HL114086NHLBI NIH HHS T32 HL069766NIDDK NIH HHS R01 DK117850
6 · The paper itself

Abstract

objectiveIn biomanufacturing there is a need for quantitative methods to map cell viability and density inside 3D bioreactors to assess health and proliferation over time. Recently, noninvasive MRI readouts of cell density have been achieved. However, the ratio of live to dead cells was not varied. Herein we present an approach for measuring the viability of cells embedded in a hydrogel independently from cell density to map cell number and health.

methodsIndependent quantification of cell viability and density was achieved by calibrating the

resultsUsing this method, the limits of detection (LODs) of total cell density and viable cell density were found to be 3.88 ×10

conclusionThis mapping technique provides a noninvasive means of visualizing cell viability and number density within optically opaque bioreactors. SIGNIFICANCE: We anticipate that such nondestructive readouts will provide valuable feedback for monitoring and controlling cell populations in bioreactors.

Indexed as

HydrogelsMagnetic Resonance ImagingCell CountCell SurvivalMagnetic Resonance SpectroscopyHydrogels

Identifiers

PMID33531296
PMCPMC8326301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.